Axovan Overview
- Year Founded
-
2000
- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$39.8M
Axovan General Information
Description
Operator of a biopharmaceutical research company intended to create novel drugs. The company is involved in the discovery of drugs linked to G protein-coupled receptors, enabling patients to receive drugs at a short span of time.
Contact Information
Website
www.axovan.comCorporate Office
- Gewerbestrasse 16
- 4123 Allschwil
- Switzerland
Corporate Office
- Gewerbestrasse 16
- 4123 Allschwil
- Switzerland
Axovan Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Merger/Acquisition | 31-Oct-2003 | $39.8M | Completed | Generating Revenue | ||
| 2. Early Stage VC | 22-Apr-2002 | Completed | Generating Revenue | |||
| 1. Early Stage VC | 01-Jun-2000 | $4.68M | $4.68M | Completed | Product Development |
Axovan Former Investors (9)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Atlas Venture | Venture Capital | Minority | ||
| Banque Cantonale Vaudoise | Corporation | Minority | ||
| Endeavour Vision | Venture Capital | Minority | ||
| HBM Healthcare Investments | Venture Capital | Minority | ||
| HBM Partners | Venture Capital | Minority |
Axovan FAQs
-
When was Axovan founded?
Axovan was founded in 2000.
-
Where is Axovan headquartered?
Axovan is headquartered in Allschwil, Switzerland.
-
What industry is Axovan in?
Axovan’s primary industry is Drug Discovery.
-
Is Axovan a private or public company?
Axovan is a Private company.
-
What is the current valuation of Axovan?
The current valuation of Axovan is .
-
What is Axovan’s current revenue?
The current revenue for Axovan is .
-
How much funding has Axovan raised over time?
Axovan has raised $22.7M.
-
Who are Axovan’s investors?
Atlas Venture, Banque Cantonale Vaudoise, Endeavour Vision, HBM Healthcare Investments, and HBM Partners are 5 of 9 investors who have invested in Axovan.
-
When was Axovan acquired?
Axovan was acquired on 31-Oct-2003.
-
Who acquired Axovan?
Axovan was acquired by Actelion Pharmaceuticals.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process